徐罡

    【摘要】 目的：探討左西孟旦对慢性心力衰竭患者心室重塑及心脏储备功能的影响。方法：选取2018年1月-2020年1月本院收治的慢性心力衰竭患者86例为研究对象。按照随机数字表法分为试验组(常规治疗+左西孟旦治疗)和对照组(常规治疗)，各43例。分别于治疗前后测定两组心室重塑、心脏储备功能、炎症因子等指标，比较两组疗效与安全性。结果：治疗前，两组心室重塑、心脏储备功能、炎症因子等指标比较，差异均无统计学意义(P>0.05);治疗后，试验组心室重塑、心脏储备功能、炎症因子等指标均优于对照组(P0.05);治疗后，试验组Lee氏心衰积分低于对照组(P0.05)。结论：左西孟旦在慢性心力衰竭患者治疗中的效果较好，可有效改善其心室重塑与心脏储备功能指标，抑制炎症反应，且安全性较好，应用价值较高。

    【关键词】 左西孟旦 慢性心力衰竭 心室重塑 心脏储备功能

    [Abstract] Objective： To investigate the effect of Levosimendan on ventricular remodeling and cardiac reserve function in patients with chronic heart failure. Method： A total of 86 patients with chronic heart failure in our hospital from January 2018 to January 2020 were selected as the research objects. They were randomly divided into the experimental group (conventional treatment + Levosimendan treatment) and the control group (conventional treatment) ......